assessment of ivermectin therapeutic efficacy on third-stage larvae of lagochilascaris minor in mice experimentally infected

Clicks: 256
ID: 152721
1998
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #82 of 173 articles by views in 2017 12th international conference for internet technology and secured transactions, icitst 2017

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 173 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
In this study we evaluated the potential action of ivermectin on third-stage larvae, both at migratory and encysted phases, in mouse tissues after experimental infection with Lagochilascaris minor. Study groups I and II consisted of 120 mice that were orally administered 1,000 parasite eggs. In order to assess ivermectin action upon migratory larvae, group I (60 mice) was equally split in three subgroups, namely I-A, I-B, and I-C. On the 7th day after inoculation (DAI), each animal from the subgroup I-A was treated with 200 µg/Kg ivermectin while subgroup I-B was given 1,000 µg/Kg, both groups received a single subcutaneous dose. To assess the drug action on encysted larvae, group II was equally split in three subgroups, namely II-A, II-B, II-C. On the 45th DAI each animal was treated with ivermectin at 200 µg/Kg (subgroup II-A) and 1,000 µg/Kg (group II-B) with a single subcutaneous dose. Untreated animals of subgroups I-C and II-C were used as controls. On the 60th DAI all animals were submitted to larva search. At a dose of 1,000 µg/Kg the drug had 99.5% effectiveness on third-stage migratory larvae (subgroup I-B). Ivermectin efficacy was lower than 5% on third-stage encysted larvae for both doses as well as for migratory larvae treated with 200µg/Kg.
Avaliação da eficácia terapêutica da Ivermectina sobre larvas de terceiro estádio de Lagochilascaris minor em camundongos infectados experimentalmente Avaliou-se a ação da ivermectina sobre larvas de 3o estádio, tanto em fase de migração, quanto larvas encistadas em tecidos de camundongos infectados experimentalmente com Lagochilascaris minor. Foram utilizados 120 camundongos (grupos I e II), sendo que cada animal foi inoculado, por via oral, com 1.000 ovos do parasito. Para verificar a ação da ivermectina sobre larvas em migração, o grupo I (60 animais) foi dividido igualmente em três subgrupos: I-A, I-B e I-C. No 7o dia após a inoculação (DAI), cada animal foi tratado com ivermectina na dosagem de 200 µg/Kg (subgrupo I-A) e 1.000 µg/Kg/dose única/via sc (subgrupo I-B). Com o objetivo de verificar a ação da droga sobre larvas encistadas, os animais do grupo II foram divididos igualmente em três subgrupos: II-A, II-B e II-C; no 45o DAI cada animal foi tratado com ivermectina na dosagem de 200 µg/Kg (subgrupo II-A) e 1.000 µg/Kg/dose única/via sc, (subgrupo II-B). Os animais dos subgrupos I-C e II-C constituíram o grupo controle. No 60o DAI todos os animais foram submetidos à pesquisa de larvas. Observou-se 99,5% de eficácia da droga na dosagem de 1.000 µg/Kg (grupo IB) sobre larvas de 3o estádio em fase de migração e eficácia inferior a 5% sobre larvas de 3o estádio encistadas, em ambas dosagens, bem como sobre larvas em migração na dosagem de 200 µg/Kg.
Reference Key
barbosa1998revistaassessment Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal 2017 12th international conference for internet technology and secured transactions, icitst 2017
Year 1998
DOI
10.1590/S0036-46651998000300002
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.